• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单导联心脏再同步化与除颤治疗在动物模型中的可行性

Feasibility of Single-lead Cardiac Resynchronization and Defibrillation Therapy in an Animal Model.

作者信息

Varela Daniel, Sandhu Amneet, Zipse Matthew, Aleong Ryan Gerrard

机构信息

Cardiology Department, University of Colorado Hospital, Aurora, CO, USA.

Cardiology Department, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA.

出版信息

J Innov Card Rhythm Manag. 2024 Aug 15;15(8):5985-5989. doi: 10.19102/icrm.2024.15081. eCollection 2024 Aug.

DOI:10.19102/icrm.2024.15081
PMID:39193537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11346499/
Abstract

Conduction system pacing (CSP) has emerged as an alternative to cardiac resynchronization therapy (CRT); however, there is limited experience with CSP using implantable cardiac defibrillator (ICD) leads. The achievement of CSP with an ICD lead may yield comparable results to cardiac resynchronization therapy defibrillator (CRT-D) therapy using fewer leads. We implanted the Biotronik Linox DX "VDD"-programmable ICD lead in a swine model to investigate the feasibility of "single-lead" CRT-D implantation. With the lead embedded in the basal right ventricular septum, morphologic criteria for CSP were achieved, and successful defibrillation was performed while maintaining atrial sensing. Future work may assure reproducibility of these findings and further determine the feasibility of a single-lead CRT-D.

摘要

传导系统起搏(CSP)已成为心脏再同步治疗(CRT)的一种替代方法;然而,使用植入式心脏除颤器(ICD)导线进行CSP的经验有限。使用ICD导线实现CSP可能会产生与使用较少导线的心脏再同步治疗除颤器(CRT-D)疗法相当的结果。我们在猪模型中植入了百多力Linox DX“VDD”可编程ICD导线,以研究“单导线”CRT-D植入的可行性。将导线嵌入右心室基底部间隔后,达到了CSP的形态学标准,并且在维持心房感知的同时成功进行了除颤。未来的工作可能会确保这些发现的可重复性,并进一步确定单导线CRT-D的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/75157549d2c3/icrm-15-5985-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/15a921faed19/icrm-15-5985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/c702a5bfbb3c/icrm-15-5985-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/dc226499a3b5/icrm-15-5985-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/75157549d2c3/icrm-15-5985-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/15a921faed19/icrm-15-5985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/c702a5bfbb3c/icrm-15-5985-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/dc226499a3b5/icrm-15-5985-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c38/11346499/75157549d2c3/icrm-15-5985-g004.jpg

相似文献

1
Feasibility of Single-lead Cardiac Resynchronization and Defibrillation Therapy in an Animal Model.单导联心脏再同步化与除颤治疗在动物模型中的可行性
J Innov Card Rhythm Manag. 2024 Aug 15;15(8):5985-5989. doi: 10.19102/icrm.2024.15081. eCollection 2024 Aug.
2
Dual-chamber ICD for left bundle branch area pacing: the cardiac resynchronization and arrhythmia sensing via the left bundle (cross-left) pilot study.双腔 ICD 用于左束支区域起搏:通过左束(交叉左)先导研究进行心脏再同步和心律失常感知。
J Interv Card Electrophysiol. 2023 Jun;66(4):905-912. doi: 10.1007/s10840-022-01342-6. Epub 2022 Aug 16.
3
Complications of permanent cardiac pacing in patients with persistent left superior vena cava.永存左上腔静脉患者永久性心脏起搏的并发症
Cardiol J. 2014;21(2):128-37. doi: 10.5603/CJ.a2014.0006. Epub 2014 Feb 14.
4
The efficacy of the Linox DX ICD lead from a single center experience.来自单一中心经验的Linox DX植入式心律转复除颤器导线的疗效。
Indian Pacing Electrophysiol J. 2020 Jul-Aug;20(4):137-140. doi: 10.1016/j.ipej.2019.12.014. Epub 2019 Dec 17.
5
Left bundle branch pacing-optimized implantable cardioverter-defibrillator (LOT-ICD) for cardiac resynchronization therapy: A pilot study.用于心脏再同步治疗的左束支起搏优化型植入式心脏复律除颤器(LOT-ICD):一项初步研究。
Heart Rhythm O2. 2022 Dec 16;3(6Part B):723-727. doi: 10.1016/j.hroo.2022.08.004. eCollection 2022 Dec.
6
Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.双心室起搏(心脏再同步治疗):基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.
7
Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry.体重指数与心脏再同步治疗意图和左心室导线植入失败的相关性:来自 NCDR 植入式心脏复律除颤器登记处的见解。
J Interv Card Electrophysiol. 2020 Mar;57(2):279-288. doi: 10.1007/s10840-019-00550-x. Epub 2019 Apr 19.
8
Conduction System Pacing Upgrade in Chronic Heart Failure with Severe Left Ventricular Dysfunction and Chronic Atrial Fibrillation.严重左心室功能不全合并慢性心房颤动的慢性心力衰竭患者传导系统起搏升级
Int Heart J. 2023 Jul 29;64(4):768-774. doi: 10.1536/ihj.22-614. Epub 2023 Jul 14.
9
Novel two-lead cardiac resynchronization therapy system provides equivalent CRT responses with less complications than a conventional three-lead system: Results from the QP ExCELs lead registry.新型双导联心脏再同步治疗系统与传统三导联系统相比,能提供同等的心脏再同步治疗效果且并发症更少:QP ExCELs导联注册研究结果
J Cardiovasc Electrophysiol. 2020 Jul;31(7):1784-1792. doi: 10.1111/jce.14552. Epub 2020 Jun 1.
10
Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.右心室导线位置对 CRT-D 患者临床结局和室性心律失常发生率的影响。
Heart Rhythm. 2013 Dec;10(12):1770-7. doi: 10.1016/j.hrthm.2013.08.020. Epub 2013 Aug 22.

引用本文的文献

1
Biventricular Cardiac Resynchronization Therapy with Atrial Sensing but No Atrial Lead: A Prospective Registry of Patients, Complications, and Therapy Responses.无心房导线的双心室心脏再同步化治疗伴心房感知:一项关于患者、并发症及治疗反应的前瞻性注册研究。
J Clin Med. 2025 Jul 15;14(14):5009. doi: 10.3390/jcm14145009.

本文引用的文献

1
Cardiac Conduction System Pacing: A Comprehensive Update.心脏传导系统起搏:全面更新。
JACC Clin Electrophysiol. 2023 Nov;9(11):2358-2387. doi: 10.1016/j.jacep.2023.06.005. Epub 2023 Aug 16.
2
Left Bundle Branch Area Defibrillator (LBBAD): A First-in-Human Feasibility Study.左束支区域除颤器(LBBAD):首例人体可行性研究。
JACC Clin Electrophysiol. 2023 May;9(5):620-627. doi: 10.1016/j.jacep.2023.01.006. Epub 2023 Mar 22.
3
Left bundle branch pacing versus biventricular pacing for cardiac resynchronization therapy: A systematic review and meta-analysis.
左束支起搏与双心室起搏治疗心脏再同步治疗的比较:系统评价和荟萃分析。
Pacing Clin Electrophysiol. 2023 May;46(5):432-439. doi: 10.1111/pace.14700. Epub 2023 Apr 10.
4
Left Bundle Branch Pacing Versus Biventricular Pacing for Acute Cardiac Resynchronization in Patients With Heart Failure.左束支起搏与双心室起搏治疗心力衰竭患者的急性心脏再同步化。
Circ Arrhythm Electrophysiol. 2022 Nov;15(11):e011181. doi: 10.1161/CIRCEP.122.011181. Epub 2022 Oct 28.
5
ECG and Pacing Criteria for Differentiating Conduction System Pacing from Myocardial Pacing.区分传导系统起搏与心肌起搏的心电图及起搏标准
Arrhythm Electrophysiol Rev. 2021 Oct;10(3):172-180. doi: 10.15420/aer.2021.26.
6
A comparative anatomic and physiologic overview of the porcine heart.猪心脏的比较解剖学和生理学概述。
J Am Assoc Lab Anim Sci. 2014 Sep;53(5):432-8.
7
Cardiac-resynchronization therapy for mild-to-moderate heart failure.心脏再同步治疗轻中度心力衰竭。
N Engl J Med. 2010 Dec 16;363(25):2385-95. doi: 10.1056/NEJMoa1009540. Epub 2010 Nov 14.
8
Cardiac-resynchronization therapy for the prevention of heart-failure events.心脏再同步治疗预防心力衰竭事件
N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.
9
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.晚期慢性心力衰竭患者接受或不接受植入式除颤器的心脏再同步治疗。
N Engl J Med. 2004 May 20;350(21):2140-50. doi: 10.1056/NEJMoa032423.
10
The conduction system of the swine heart.猪心脏的传导系统。
Chest. 1991 Jul;100(1):207-12. doi: 10.1378/chest.100.1.207.